Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 14, 2021 09:52 ET | Source: Oncotelic Therapeutics, Inc.

Oncotelic’s Dr. Anthony Maida to Present at 2nd Annual TGF-β for Immuno-Oncology Drug Development Summit in January 2022

AGOURA HILLS, CA, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), a leading developer of TGF-β therapeutics for oncology and virology,...
June 09, 2021 14:30 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma’s Participation in the Noble Capital Markets C-Suite Interview Series is Now Available Online

BOTHELL, Wash., June 09, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
May 17, 2021 08:00 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma Reports First Quarter 2021 Financial Results and Provides Business Update

BOTHELL, Wash., May 17, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
March 09, 2021 09:00 ET | Source: SINTX Technologies, Inc.

SINTX Technologies announces a fabric technology shown to inactivate upon contact SARS-CoV-2, the virus causing the COVID-19 pandemic

Silicon nitride-embedded fabrics proved effective against inactivating SARS-CoV-2 virusThe fabrics may be suitable for many applications, including masks, surgical gowns, and air filters ...
March 09, 2021 07:00 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma to Participate in the Virtual 33rd Annual Roth Conference

BOTHELL, Wash., March 09, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
March 02, 2021 08:00 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

BOTHELL, Wash., March 02, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
October 19, 2020 08:05 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma Provides Update on Influenza A Program

– New in vitro data demonstrating antiviral activity with lead compound CC-42344 against Xofluza (baloxavir)-resistant H1N1 strain – – Company continues to advance IND-enabling studies for...